-oxford- / iStockphoto.com
The IP concessions in the United States-Mexico-Canada Agreement (USMCA) are the latest hit for access to affordable prescription medicines for Canadians, according to the Canadian Generic Pharmaceutical Association (CGPA).
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
NAFTA, CGPA, USMCA, trade agreement, generics, biologic drugs, market exclusivity, affordable healthcare, CETA, healthcare